14-88625051-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_183387.3(EML5):c.4817C>T(p.Ala1606Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,612,450 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )
Consequence
EML5
NM_183387.3 missense
NM_183387.3 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 7.54
Genes affected
EML5 (HGNC:18197): (EMAP like 5) Predicted to enable microtubule binding activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
ZC3H14 (HGNC:20509): (zinc finger CCCH-type containing 14) The protein encoded by this gene is a poly(A)-binding protein that can affect gene expression and poly(A) tail length. The encoded protein may influence mRNA stability, nuclear export, and translation. [provided by RefSeq, May 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.34356296).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EML5 | NM_183387.3 | c.4817C>T | p.Ala1606Val | missense_variant | 36/44 | ENST00000554922.6 | NP_899243.1 | |
ZC3H14 | NM_024824.5 | c.*13300G>A | 3_prime_UTR_variant | 17/17 | ENST00000251038.10 | NP_079100.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EML5 | ENST00000554922.6 | c.4817C>T | p.Ala1606Val | missense_variant | 36/44 | 5 | NM_183387.3 | ENSP00000451998 | P4 | |
ZC3H14 | ENST00000251038.10 | c.*13300G>A | 3_prime_UTR_variant | 17/17 | 1 | NM_024824.5 | ENSP00000251038 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151350Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
151350
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 248858Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135000
GnomAD3 exomes
AF:
AC:
10
AN:
248858
Hom.:
AF XY:
AC XY:
3
AN XY:
135000
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461100Hom.: 0 Cov.: 30 AF XY: 0.0000206 AC XY: 15AN XY: 726810
GnomAD4 exome
AF:
AC:
39
AN:
1461100
Hom.:
Cov.:
30
AF XY:
AC XY:
15
AN XY:
726810
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151350Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73880
GnomAD4 genome
AF:
AC:
4
AN:
151350
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
73880
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.4817C>T (p.A1606V) alteration is located in exon 36 (coding exon 36) of the EML5 gene. This alteration results from a C to T substitution at nucleotide position 4817, causing the alanine (A) at amino acid position 1606 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;D
Sift4G
Uncertain
D;D;.
Polyphen
D;D;.
Vest4
MutPred
0.48
.;Gain of catalytic residue at N1602 (P = 0);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at